Development of Potent and Selective PfCLK3 Inhibitors Based on GSK-TCMDC151 as a New Class of Antimalarials

doi 10.26434/chemrxiv.9817202.v1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)


Related search